Suchergebnisse - "Yokoyama, Keitaro"

PubPharm (30)

1

Changes in erythropoiesis-stimulating agent responsiveness after transfer to combined therapy with peritoneal dialysis and hemodialysis for patients on peritoneal dialysis : A prospective multicenter study in Japan

enthalten in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy | 2023

von Maruyama, Y. | Yokoyama, K. | Higuchi, C. | +9

2

Clinical feasibility of transfer to combined therapy with peritoneal dialysis and hemodialysis for patients on peritoneal dialysis : A prospective multicenter study in Japan

enthalten in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy | 2022

von Maruyama, Y. | Yokoyama, K. | Higuchi, C. | +9

3

First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis : Pharmacokinetic and Pharmacodynamic Properties

enthalten in: Clinical pharmacokinetics | 2022

von Kazama, J. | Koiwa, F. | Yokoyama, K. | +4

4

Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease : a long-term, real-world, observational, post-marketing surveillance study

enthalten in: Clinical and experimental nephrology | 2022

von Yokoyama, K. | Hashimoto, T. | Okuda, Y. | +5

5

Ferric citrate hydrate is associated with a reduced cost of drugs and a smaller change in red blood cell distribution width

enthalten in: Scientific reports | 2022

von Ito, K. | Yokoyama, K. | Nakayama, M. | +2

6

Association of fibroblast growth factor 23 and α-klotho in hemodialysis patients during administration of ferric citrate hydrate : post hoc analysis of ASTRIO study

enthalten in: BMC nephrology | 2021

von Ito, K. | Yokoyama, K. | Nakayama, M. | +2

7

Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis : The LANDMARK Randomized Clinical Trial

enthalten in: JAMA | 2021

von Ogata, H. | Fukagawa, M. | Hirakata, H. | +104

8

Influence of dialysate Ca concentrations on the therapeutic effects of etelcalcetide with concomitant drugs in patients with secondary hyperparathyroidism

enthalten in: Nephrology (Carlton, Vic.) | 2020

von Shigematsu, T. | Fukagawa, M. | Yokoyama, K. | +4

9

Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia : ASTRIO study

enthalten in: Scientific reports | 2019

von Yokoyama, K. | Fukagawa, M. | Akiba, T. | +5

10

Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis

enthalten in: Scientific reports | 2019

von Yokoyama, K. | Shimazaki, R. | Fukagawa, M. | +17